The team will use the five-year funding to develop a liquid biopsy-based assay to select and prioritize liver cancer patients who need a liver transplant.
The National Human Genome Research Institute and the National Cancer Institute also intend to fund the dissemination of genomic resources to the research community.
Gladstone Institutes researchers will use proteomic, genomic, and gene-altering approaches to investigate apoe4 toxicity as part of a five-year project.
The panels will select candidate genes that will have a high impact on clinical practice in areas of high priority for participating institutes and centers.
The five-year funding commitment represents a 5 percent increase over the previous grant period for the rapidly growing archive of 3D protein structures.
The Hayward, California-based firm aims to tailor its NX One sample prep platform to isolate and detect cancer stem cells in urothelial cancer of the bladder.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.
